Pathogenesis, biology, and management of myelodysplastic syndromes in children

[1] ARICO M, 1993, HAEMATOLOGICA, V78, P264

[2] Myelodysplastic syndromes in childhood: Report of 49 patients from a French multicentre study [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) : 344 - 350

[3] BARANGER L, 1990, LEUKEMIA, V4, P345

[4] Barnard DR, 1996, LEUKEMIA, V10, P5

[5] MOLECULAR GENETIC-ASPECTS OF MYELODYSPLASTIC SYNDROMES [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (03) : 557 - 570

[6] BENAIM E, 1995, BRIT J HAEMATOL, V89, P947

[7] THE CHRONIC MYELOID LEUKEMIAS - GUIDELINES FOR DISTINGUISHING CHRONIC GRANULOCYTIC, ATYPICAL CHRONIC MYELOID, AND CHRONIC MYELOMONOCYTIC LEUKEMIA - PROPOSALS BY THE FRENCH-AMERICAN-BRITISH-COOPERATIVE-LEUKEMIA-GROUP [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) : 746 - 754

[8] PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 189 - 199

[9] Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J]. NATURE GENETICS, 1996, 12 (02) : 144 - 148

[10] BRANDWEIN JM, 1990, AM J PEDIAT HEMATOL, V12, P63

[1] ARICO M, 1993, HAEMATOLOGICA, V78, P264

[2] Myelodysplastic syndromes in childhood: Report of 49 patients from a French multicentre study [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (02) : 344 - 350

[3] BARANGER L, 1990, LEUKEMIA, V4, P345

[4] Barnard DR, 1996, LEUKEMIA, V10, P5

[5] MOLECULAR GENETIC-ASPECTS OF MYELODYSPLASTIC SYNDROMES [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (03) : 557 - 570

[6] BENAIM E, 1995, BRIT J HAEMATOL, V89, P947

[7] THE CHRONIC MYELOID LEUKEMIAS - GUIDELINES FOR DISTINGUISHING CHRONIC GRANULOCYTIC, ATYPICAL CHRONIC MYELOID, AND CHRONIC MYELOMONOCYTIC LEUKEMIA - PROPOSALS BY THE FRENCH-AMERICAN-BRITISH-COOPERATIVE-LEUKEMIA-GROUP [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) : 746 - 754

[8] PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 189 - 199

[9] Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J]. NATURE GENETICS, 1996, 12 (02) : 144 - 148

[10] BRANDWEIN JM, 1990, AM J PEDIAT HEMATOL, V12, P63